School of Medicine, Department of Bioethics & Humanities, University of Washington, Seattle, Washington, USA
CUHK Centre for Bioethics, The Chinese University of Hong Kong Faculty of Medicine, Shatin, New Territories, Hong Kong.
J Med Ethics. 2022 Mar;48(3):169-172. doi: 10.1136/medethics-2021-107763. Epub 2021 Nov 23.
Since the World Health Organization (WHO) first declared the novel coronavirus a pandemic, diverse strategies have emerged to address it. This paper focuses on two leading strategies, elimination and mitigation, and examines their ethical basis. Elimination or 'Zero-COVID' dominates policies in Pacific Rim societies. It sets as a goal zero deaths and seeks to contain transmission using stringent short-term lockdowns, followed by strict find, test, trace and isolate methods. Mitigation, which dominates in the US and most European nations, sets targets for community transmission and lifts restrictions once targets are met. This approach takes calculated risks and regards a certain amount of disease and death as ethically justified. Section I examines different societal responses to risk that underlie these different policy approaches. Section II focuses on ethical arguments favouring Zero-COVID and raises health equity objections. Section III proposes a long-term strategy that balances the twin goals of promoting population health and health equity.
自世界卫生组织(WHO)首次宣布新型冠状病毒大流行以来,出现了多种应对策略。本文重点关注两种主要策略,即消除和缓解,并探讨其伦理基础。消除或“零新冠”策略主导着环太平洋地区社会的政策。该策略将零死亡作为目标,通过严格的短期封锁来控制传播,然后采用严格的发现、检测、追踪和隔离方法。缓解策略主导着美国和大多数欧洲国家的政策,为社区传播设定目标,并在达到目标后解除限制。这种方法是权衡风险的,认为一定程度的疾病和死亡在伦理上是合理的。第一节探讨了这些不同政策方法所依据的不同社会对风险的反应。第二节重点讨论了支持“零新冠”的伦理论点,并提出了卫生公平方面的反对意见。第三节提出了一种平衡促进人口健康和卫生公平双重目标的长期策略。